Cysteinyl leukotrienes, acting partly on endothelial CysLT(1) receptors, mediate the contractile response to angiotensin II in the aorta of spontaneously hypertensive rats.
No takes yet. Share an insight, caveat, or question.
Does not support clinical use of 5-lipoxygenase inhibition; leaves open leukotriene mediation of angiotensin II effects in human hypertension.
F. Stanke-Labesque (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: